VOYA Investment Management
TXMD icon

VOYA Investment Management’s TherapeuticsMD TXMD Stock Holding History

VOYA Investment Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,587
Closed -$49K – 2893
2022
Q1 		$49K Hold
2,587
– – ﹤0.01% 2595
2021
Q4 		$46K Sell
2,587
-231
-8% -$6.92K ﹤0.01% 2748
2021
Q3 		$104K Hold
2,818
– – ﹤0.01% 2727
2021
Q2 		$168K Hold
2,818
– – ﹤0.01% 2654
2021
Q1 		$189K Buy
2,818
+654
+30% +$51.2K ﹤0.01% 2558
2020
Q4 		$131K Buy
2,164
+502
+30% +$34.3K ﹤0.01% 2513
2020
Q3 		$131K Hold
1,662
– – ﹤0.01% 2284
2020
Q2 		$104K Sell
1,662
-490
-23% -$28.5K ﹤0.01% 2330
2020
Q1 		$114K Hold
2,152
– – ﹤0.01% 2309
2019
Q4 		$260K Buy
2,152
+554
+35% +$79.7K ﹤0.01% 2250
2019
Q3 		$290K Sell
1,598
-28,647
-95% -$4.04M ﹤0.01% 2066
2019
Q2 		$3.93M Sell
30,245
-30,557
-50% -$5.48M 0.01% 869
2019
Q1 		$14.8M Buy
60,802
+279
+0.5% +$73.8K 0.03% 456
2018
Q4 		$11.5M Sell
60,523
-11,002
-15% -$2.68M 0.03% 497
2018
Q3 		$23.5M Buy
71,525
+3,142
+5% +$963K 0.05% 388
2018
Q2 		$21.3M Buy
68,383
+4,859
+8% +$1.48M 0.05% 422
2018
Q1 		$15.5M Sell
63,524
-2,810
-4% -$788K 0.03% 483
2017
Q4 		$20M Buy
66,334
+1,785
+3% +$497K 0.04% 418
2017
Q3 		$17.1M Buy
64,549
+5,367
+9% +$1.55M 0.04% 444
2017
Q2 		$15.6M Buy
59,182
+14,832
+33% +$3.72M 0.03% 465
2017
Q1 		$16M Buy
44,350
+43,045
+3,298% +$13.3M 0.04% 454
2016
Q4 		$377K Hold
1,305
– – ﹤0.01% 1914
2016
Q3 		$444 Hold
1,305
– – ﹤0.01% 1789
2016
Q2 		$555K Buy
1,305
+154
+13% +$63.5K ﹤0.01% 1637
2016
Q1 		$368K Hold
1,151
– – ﹤0.01% 1886
2015
Q4 		$597K Hold
1,151
– – ﹤0.01% 1602
2015
Q3 		$337K Sell
1,151
-204
-15% -$72.5K ﹤0.01% 1972
2015
Q2 		$532K Hold
1,355
– – ﹤0.01% 1881
2015
Q1 		$410K Hold
1,355
– – ﹤0.01% 2038
2014
Q4 		$301K Hold
1,355
– – ﹤0.01% 2265
2014
Q3 		$314K Hold
1,355
– – ﹤0.01% 2233
2014
Q2 		$299K Hold
1,355
– – ﹤0.01% 2350
2014
Q1 		$427K Hold
1,355
– – ﹤0.01% 2090
2013
Q4 		$353K Hold
1,355
– – ﹤0.01% 2212
2013
Q3 		$198K Hold
1,355
– – ﹤0.01% 2487
2013
Q2 		$205K Buy
+1,355
New +$186K ﹤0.01% 2484

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

VOYA Investment Management's TXMD Position: Q2 2022 in Review

VOYA Investment Management sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 2,587 shares — an estimated $49K sold.

VOYA Investment Management first reported a position in TXMD in Q2 2013 and held it in 36 quarters. The position peaked at $23.5M in Q3 2018. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • VOYA Investment Management reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 2,587 TherapeuticsMD shares in Q2 2022, an estimated $49K.
  • VOYA Investment Management first reported a position in TherapeuticsMD in Q2 2013 and held it in 36 quarters.
  • VOYA Investment Management's TherapeuticsMD position peaked at $23.5M in Q3 2018.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.